Evotec and Variant Bio Partner to Discover and Develop Fibrosis Treatments
The Hamburg headquartered publicly listed drug discovery and development company Evotec and Variant Bio, a US-based biotech company leveraging the
Read moreThe Hamburg headquartered publicly listed drug discovery and development company Evotec and Variant Bio, a US-based biotech company leveraging the
Read morePreclinical data shows that Nutcracker’s mRNA drug candidate NTX-470 effectively targets CD3 T cells, demonstrating selective engagement with minimal unintended
Read moreAdvanced single-cell technologies, particularly methods such as single-cell RNA sequencing (scRNA-seq), coupled with sophisticated computational tools and the increasing accessibility
Read moreMMI has introduced the next generation of laser microdissection systems – the CellCut. Breakthrough Advancements for Clean and Precise Dissection This
Read moreDetermination of the Plasma Protein Binding of Liraglutide Using the EScalate* Equilibrium Shift Assay A Sovicell White Paper Evaluation of
Read moreThe use of Fluorescence Cross-Correlation Spectroscopy (FCCS) in Drug Discovery and Development An Intana Bioscience .pdf Case Study/Presentation The .pdf
Read moreReadyCell has developed an advanced range of ready-to-use HEK293 Cell-based In Vitro Plates for studying uptake drug-transporter interactions in preclinical
Read moreCutting-edge CacoReady Cell-based Plates with pre-developed Caco-2 cells for in vitro permeability assessment have been a key tool in a
Read moreReadyCell has developed an advanced range of MDCKII Cell-based Plates for In Vitro Drug-transporter Studies in preclinical testing and drug
Read moreThe Caco-2 and HT-29 Co-culture Intestinal Absorption cell-based plates are a ready-to-use in vitro cell-based model for intestinal absorption evaluation
Read more